Clinical trial
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
NCT00202579 · Institut de Recherches Internationales Servier, Other · Completed
Key facts
| NCT number | NCT00202579 |
|---|---|
| Title | Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure |
| Official title | Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients |
| Lead sponsor | Institut de Recherches Internationales Servier, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Ivabradine |
| Enrollment | 12 |
| Start date | Sep 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 25, 2024 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: